Selected research
Industry Research
Consumer Healthcare Industry Research Report 2026
Market perspective
The global Consumer Healthcare market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Consumer Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Consumer Healthcare is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Consumer Healthcare is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Consumer Healthcare include Abbott Laboratories, Glenmark Pharmaceuticals Ltd., Ipsen, Sanofi S.A., Piramal Enterprises Ltd., Sun Pharmaceuticals Ltd., Bayer AG, GlaxosmithKline plc, GSK and Pfizer, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Consumer Healthcare market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Consumer Healthcare Market by Company
Abbott Laboratories
Glenmark Pharmaceuticals Ltd.
Ipsen, Sanofi S.A.
Piramal Enterprises Ltd.
Sun Pharmaceuticals Ltd.
Bayer AG
GlaxosmithKline plc
GSK
Pfizer, Inc.
Mylan
Merck
Johnson & Johnson
Sanofi
Consumer Healthcare Segment by Type
Respiratory Product
Oral Health Product
Skin Health Product
Nutrition/Gastro Intestinal Product
Pain Relief Product
Consumer Healthcare Segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Consumer Healthcare Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Consumer Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Consumer Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Consumer Healthcare.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Consumer Healthcare manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Consumer Healthcare by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Consumer Healthcare in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Respiratory Product
- Oral Health Product
- Skin Health Product
- Nutrition/Gastro Intestinal Product
- Pain Relief Product
Applications
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Companies covered
- Abbott Laboratories
- Glenmark Pharmaceuticals Ltd.
- Ipsen, Sanofi S.A.
- Piramal Enterprises Ltd.
- Sun Pharmaceuticals Ltd.
- Bayer AG
- GlaxosmithKline plc
- GSK
- Pfizer, Inc.
- Mylan
- Merck
- Johnson & Johnson
- Sanofi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Consumer Healthcare Market Size (2021-2032)
- 2.2.2 Global Consumer Healthcare Sales (2021-2032)
- 2.2.3 Global Consumer Healthcare Market Average Price (2021-2032)
- 2.3 Consumer Healthcare by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Respiratory Product
- 2.3.3 Oral Health Product
- 2.3.4 Skin Health Product
- 2.3.5 Nutrition/Gastro Intestinal Product
- 2.3.6 Pain Relief Product
- 2.4 Consumer Healthcare by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Online Pharmacy
- 2.4.4 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Consumer Healthcare Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Consumer Healthcare Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Consumer Healthcare Revenue of Manufacturers (2021-2026)
- 3.4 Global Consumer Healthcare Average Price by Manufacturers (2021-2026)
- 3.5 Global Consumer Healthcare Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Consumer Healthcare, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Consumer Healthcare, Product Type & Application
- 3.8 Global Manufacturers of Consumer Healthcare, Established Date
- 3.9 Global Consumer Healthcare Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott Laboratories
- 4.1.1 Abbott Laboratories Company Information
- 4.1.2 Abbott Laboratories Business Overview
- 4.1.3 Abbott Laboratories Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Laboratories Consumer Healthcare Product Portfolio
- 4.1.5 Abbott Laboratories Recent Developments
- 4.2 Glenmark Pharmaceuticals Ltd.
- 4.2.1 Glenmark Pharmaceuticals Ltd. Company Information
- 4.2.2 Glenmark Pharmaceuticals Ltd. Business Overview
- 4.2.3 Glenmark Pharmaceuticals Ltd. Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Glenmark Pharmaceuticals Ltd. Consumer Healthcare Product Portfolio
- 4.2.5 Glenmark Pharmaceuticals Ltd. Recent Developments
- 4.3 Ipsen, Sanofi S.A.
- 4.3.1 Ipsen, Sanofi S.A. Company Information
- 4.3.2 Ipsen, Sanofi S.A. Business Overview
- 4.3.3 Ipsen, Sanofi S.A. Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Ipsen, Sanofi S.A. Consumer Healthcare Product Portfolio
- 4.3.5 Ipsen, Sanofi S.A. Recent Developments
- 4.4 Piramal Enterprises Ltd.
- 4.4.1 Piramal Enterprises Ltd. Company Information
- 4.4.2 Piramal Enterprises Ltd. Business Overview
- 4.4.3 Piramal Enterprises Ltd. Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Piramal Enterprises Ltd. Consumer Healthcare Product Portfolio
- 4.4.5 Piramal Enterprises Ltd. Recent Developments
- 4.5 Sun Pharmaceuticals Ltd.
- 4.5.1 Sun Pharmaceuticals Ltd. Company Information
- 4.5.2 Sun Pharmaceuticals Ltd. Business Overview
- 4.5.3 Sun Pharmaceuticals Ltd. Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sun Pharmaceuticals Ltd. Consumer Healthcare Product Portfolio
- 4.5.5 Sun Pharmaceuticals Ltd. Recent Developments
- 4.6 Bayer AG
- 4.6.1 Bayer AG Company Information
- 4.6.2 Bayer AG Business Overview
- 4.6.3 Bayer AG Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bayer AG Consumer Healthcare Product Portfolio
- 4.6.5 Bayer AG Recent Developments
- 4.7 GlaxosmithKline plc
- 4.7.1 GlaxosmithKline plc Company Information
- 4.7.2 GlaxosmithKline plc Business Overview
- 4.7.3 GlaxosmithKline plc Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GlaxosmithKline plc Consumer Healthcare Product Portfolio
- 4.7.5 GlaxosmithKline plc Recent Developments
- 4.8 GSK
- 4.8.1 GSK Company Information
- 4.8.2 GSK Business Overview
- 4.8.3 GSK Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 GSK Consumer Healthcare Product Portfolio
- 4.8.5 GSK Recent Developments
- 4.9 Pfizer, Inc.
- 4.9.1 Pfizer, Inc. Company Information
- 4.9.2 Pfizer, Inc. Business Overview
- 4.9.3 Pfizer, Inc. Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer, Inc. Consumer Healthcare Product Portfolio
- 4.9.5 Pfizer, Inc. Recent Developments
- 4.10 Mylan
- 4.10.1 Mylan Company Information
- 4.10.2 Mylan Business Overview
- 4.10.3 Mylan Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mylan Consumer Healthcare Product Portfolio
- 4.10.5 Mylan Recent Developments
- 4.11 Merck
- 4.11.1 Merck Company Information
- 4.11.2 Merck Business Overview
- 4.11.3 Merck Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Merck Consumer Healthcare Product Portfolio
- 4.11.5 Merck Recent Developments
- 4.12 Johnson & Johnson
- 4.12.1 Johnson & Johnson Company Information
- 4.12.2 Johnson & Johnson Business Overview
- 4.12.3 Johnson & Johnson Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Johnson & Johnson Consumer Healthcare Product Portfolio
- 4.12.5 Johnson & Johnson Recent Developments
- 4.13 Sanofi
- 4.13.1 Sanofi Company Information
- 4.13.2 Sanofi Business Overview
- 4.13.3 Sanofi Consumer Healthcare Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Sanofi Consumer Healthcare Product Portfolio
- 4.13.5 Sanofi Recent Developments
5 Global Consumer Healthcare Market Scenario by Region
- 5.1 Global Consumer Healthcare Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Consumer Healthcare Sales by Region: 2021-2032
- 5.2.1 Global Consumer Healthcare Sales by Region: 2021-2026
- 5.2.2 Global Consumer Healthcare Sales by Region: 2027-2032
- 5.3 Global Consumer Healthcare Revenue by Region: 2021-2032
- 5.3.1 Global Consumer Healthcare Revenue by Region: 2021-2026
- 5.3.2 Global Consumer Healthcare Revenue by Region: 2027-2032
- 5.4 North America Consumer Healthcare Market Facts & Figures by Country
- 5.4.1 North America Consumer Healthcare Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Consumer Healthcare Sales by Country (2021-2032)
- 5.4.3 North America Consumer Healthcare Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Consumer Healthcare Market Facts & Figures by Country
- 5.5.1 Europe Consumer Healthcare Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Consumer Healthcare Sales by Country (2021-2032)
- 5.5.3 Europe Consumer Healthcare Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Consumer Healthcare Market Facts & Figures by Country
- 5.6.1 Asia Pacific Consumer Healthcare Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Consumer Healthcare Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Consumer Healthcare Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Consumer Healthcare Market Facts & Figures by Country
- 5.7.1 South America Consumer Healthcare Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Consumer Healthcare Sales by Country (2021-2032)
- 5.7.3 South America Consumer Healthcare Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Consumer Healthcare Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Consumer Healthcare Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Consumer Healthcare Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Consumer Healthcare Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Consumer Healthcare Sales by Type (2021-2032)
- 6.1.1 Global Consumer Healthcare Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Consumer Healthcare Sales Market Share by Type (2021-2032)
- 6.2 Global Consumer Healthcare Revenue by Type (2021-2032)
- 6.2.1 Global Consumer Healthcare Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Consumer Healthcare Revenue Market Share by Type (2021-2032)
- 6.3 Global Consumer Healthcare Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Consumer Healthcare Sales by Application (2021-2032)
- 7.1.1 Global Consumer Healthcare Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Consumer Healthcare Sales Market Share by Application (2021-2032)
- 7.2 Global Consumer Healthcare Revenue by Application (2021-2032)
- 7.2.1 Global Consumer Healthcare Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Consumer Healthcare Revenue Market Share by Application (2021-2032)
- 7.3 Global Consumer Healthcare Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Consumer Healthcare Value Chain Analysis
- 8.1.1 Consumer Healthcare Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Consumer Healthcare Production Mode & Process
- 8.2 Consumer Healthcare Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Consumer Healthcare Distributors
- 8.2.3 Consumer Healthcare Customers
9 Global Consumer Healthcare Analyzing Market Dynamics
- 9.1 Consumer Healthcare Industry Trends
- 9.2 Consumer Healthcare Industry Drivers
- 9.3 Consumer Healthcare Industry Opportunities and Challenges
- 9.4 Consumer Healthcare Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst